|
1
|
Solomon VR and Lee H: Chloroquine and its
analogs: A new promise of an old drug for effective and safe cancer
therapies. Eur J Pharmacol. 625:220–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Augustijns P, Geusens P and Verbeke N:
Chloroquine levels in blood during chronic treatment of patients
with rheumatoid arthritis. Eur J Clin Pharmacol. 42:429–433.
1992.PubMed/NCBI
|
|
3
|
Bezerra EL, Vilar MJ, da Trindade Neto PB
and Sato EI: Double-blind, randomized, controlled clinical trial of
clofazimine compared with chloroquine in patients with systemic
lupus erythematosus. Arthritis Rheum. 52:3073–3078. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liang X, Tang J, Liang Y, Jin R and Cai X:
Suppression of autophagy by chloroquine sensitizes
5-fluorouracil-mediated cell death in gallbladder carcinoma cells.
Cell Biosci. 4:102014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen P, Hu T, Liang Y, Jiang Y, Pan Y, Li
C, Zhang P, Wei D, Li P, Jeong LS, et al: Synergistic inhibition of
autophagy and neddylation pathways as a novel therapeutic approach
for targeting liver cancer. Oncotarget. 6:9002–9017. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mei L, Chen Y, Wang Z, Wang J, Wan J, Yu
C, Liu X and Li W: Synergistic anti-tumour effects of tetrandrine
and chloroquine combination therapy in human cancer: A potential
antagonistic role for p21. Br J Pharmacol. 172:2232–2245. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rahim R and Strobl JS: Hydroxychloroquine,
chloroquine, and all-trans retinoic acid regulate growth, survival,
and histone acetylation in breast cancer cells. Anticancer Drugs.
20:736–745. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lin NY, Beyer C, Giessl A, Kireva T,
Scholtysek C, Uderhardt S, Munoz LE, Dees C, Distler A, Wirtz S, et
al: Autophagy regulates TNFα-mediated joint destruction in
experimental arthritis. Ann Rheum Dis. 72:761–768. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yuan HX, Russell RC and Guan KL:
Regulation of PIK3C3/VPS34 complexes by MTOR in nutrient
stress-induced autophagy. Autophagy. 9:1983–1995. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Choi AM, Ryter SW and Levine B: Autophagy
in human health and disease. N Engl J Med. 368:1845–1846. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Galluzzi L, Pietrocola F, Bravo-San Pedro
JM, Amaravadi RK, Baehrecke EH, Cecconi F, Codogno P, Debnath J,
Gewirtz DA, Karantza V, et al: Autophagy in malignant
transformation and cancer progression. EMBO J. 34:856–880. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
White E: The role for autophagy in cancer.
J Clin Invest. 125:42–46. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu LL, Long ZJ, Wang LX, Zheng FM, Fang
ZG, Yan M, Xu DF, Chen JJ, Wang SW, Lin DJ and Liu Q: Inhibition of
mTOR pathway sensitizes acute myeloid leukemia cells to aurora
inhibitors by suppression of glycolytic metabolism. Mol Cancer Res.
11:1326–1336. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vander Heiden MG, Cantley LC and Thompson
CB: Understanding the Warburg effect: The metabolic requirements of
cell proliferation. Science. 324:1029–1033. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chiavarina B, Whitaker-Menezes D, Migneco
G, Martinez-Outschoorn UE, Pavlides S, Howell A, Tanowitz HB,
Casimiro MC, Wang C, Pestell RG, et al: HIF1-alpha functions as a
tumor promoter in cancer associated fibroblasts, and as a tumor
suppressor in breast cancer cells: Autophagy drives
compartment-specific oncogenesis. Cell Cycle. 9:3534–3551. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Morselli E, Galluzzi L, Kepp O, Mariño G,
Michaud M, Vitale I, Maiuri MC and Kroemer G: Oncosuppressive
functions of autophagy. Antioxid Redox Signal. 14:2251–2269. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gañán-Gómez I, Estañ-Omaña MC, Sancho P,
Aller P and Boyano-Adánez MC: Mechanisms of resistance to apoptosis
in the human acute promyelocytic leukemia cell line NB4. Ann
Hematol. 94:379–392. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Amaravadi RK and Thompson CB: The roles of
therapy-induced autophagy and necrosis in cancer treatment. Clin
Cancer Res. 13:7271–7279. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tasdemir E, Galluzzi L, Maiuri MC, Criollo
A, Vitale I, Hangen E, Modjtahedi N and Kroemer G: Methods for
assessing autophagy and autophagic cell death. Methods Mol Biol.
445:29–76. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fan Y, Chen M, Meng J, Yu L, Tu Y, Wan L,
Fang K and Zhu W: Arsenic trioxide and resveratrol show synergistic
anti-leukemia activity and neutralized cardiotoxicity. PLoS One.
9:e1058902014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu SS, Wang XP, Li XB, Liang JY, Liu LL,
Lu Y, Zhong XY and Chen YX: Zoledronic acid exerts antitumor
effects in NB4 acute promyelocytic leukemia cells by inducing
apoptosis and S phase arrest. Biomed Pharmacother. 68:1031–1036.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Choi JH, Yoon JS, Won YW, Park BB and Lee
YY: Chloroquine enhances the chemotherapeutic activity of
5-fluorouracil in a colon cancer cell line via cell cycle
alteration. APMIS. 120:597–604. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zheng Y, Zhao YL, Deng X, Yang S, Mao Y,
Li Z, Jiang P, Zhao X and Wei Y: Chloroquine inhibits colon cancer
cell growth in vitro and tumor growth in vivo via induction of
apoptosis. Cancer Invest. 27:286–292. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jiang PD, Zhao YL, Deng XQ, Mao YQ, Shi W,
Tang QQ, Li ZG, Zheng YZ, Yang SY and Wei YQ: Antitumor and
antimetastatic activities of chloroquine diphosphate in a murine
model of breast cancer. Biomed Pharmacother. 64:609–614. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Choi DS, Blanco E, Kim YS, Rodriguez AA,
Zhao H, Huang TH, Chen CL, Jin G, Landis MD, Burey LA, et al:
Chloroquine eliminates cancer stem cells through deregulation of
Jak2 and DNMT1. Stem Cells. 32:2309–2323. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Maes H, Kuchnio A, Peric A, Moens S, Nys
K, De Bock K, Quaegebeur A, Schoors S, Georgiadou M, Wouters J, et
al: Tumor vessel normalization by chloroquine independent of
autophagy. Cancer Cell. 26:190–206. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ratikan JA, Sayre JW and Schaue D:
Chloroquine engages the immune system to eradicate irradiated
breast tumors in mice. Int J Radiat Oncol Biol Phys. 87:761–768.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hu T, Li P, Luo Z, Chen X, Zhang J, Wang
C, Chen P and Dong Z: Chloroquine inhibits hepatocellular carcinoma
cell growth in vitro and in vivo. Oncol Rep. 35:43–49. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jiang PD, Zhao YL, Shi W, Deng XQ, Xie G,
Mao YQ, Li ZG, Zheng YZ, Yang SY and Wei YQ: Cell growth
inhibition, G2/M cell cycle arrest, and apoptosis induced by
chloroquine in human breast cancer cell line Bcap-37. Cell Physiol
Biochem. 22:431–440. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nilkaeo A, Bhuvanath S, Praputbut S and
Wisessombat S: Induction of cell cycle arrest and apoptosis in JAR
trophoblast by antimalarial drugs. Biomed Res. 27:131–137. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Romani AA, Desenzani S, Morganti MM, La
Monica S, Borghetti AF and Soliani P: Zoledronic acid determines
S-phase arrest but fails to induce apoptosis in cholangiocarcinoma
cells. Biochem Pharmacol. 78:133–141. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ohnuki H, Izumi K, Terada M, Saito T, Kato
H, Suzuki A, Kawano Y, Nozawa-Inoue K, Takagi R and Maeda T:
Zoledronic acid induces S-phase arrest via a DNA damage response in
normal human oral keratinocytes. Arch Oral Biol. 57:906–917. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tan H, Gao S, Zhuang Y, Dong Y, Guan WH,
Zhang K, Xu J and Cui J: R-Phycoerythrin induces SGC-7901 apoptosis
by arresting cell cycle at S phase. Mar Drugs. 14:E1662016.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hsu YL, Uen YH, Chen Y, Liang HL and Kuo
PL: Tricetin, a dietary flavonoid, inhibits proliferation of human
breast adenocarcinoma mcf-7 cells by blocking cell cycle
progression and inducing apoptosis. J Agric Food Chem.
57:8688–8695. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Vermeulen K, Van Bockstaele DR and
Berneman ZN: The cell cycle: A review of regulation, deregulation
and therapeutic targets in cancer. Cell Prolif. 36:131–149. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
George Rosenker KM, Paquette WD, Johnston
PA, Sharlow ER, Vogt A, Bakan A, Lazo JS and Wipf P: Synthesis and
biological evaluation of 3-aminoisoquinolin-1(2H)-one based
inhibitors of the dual-specificity phosphatase Cdc25B. Bioorg Med
Chem. 23:2810–2818. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tilaoui M, Mouse HA, Jaafari A and Zyad A:
Differential effect of artemisinin against cancer cell lines. Nat
Prod Bioprospect. 4:189–196. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Au WY, Kumana CR, Lam CW, Cheng VC, Shek
TW, Chan EY, Liu R and Kwong YL: Solid tumors subsequent to arsenic
trioxide treatment for acute promyelocytic leukemia. Leuk Res.
31:105–108. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ghavamzadeh A, Alimoghaddam K, Rostami S,
Ghaffari SH, Jahani M, Iravani M, Mousavi SA, Bahar B and Jalili M:
Phase II study of single-agent arsenic trioxide for the front-line
therapy of acute promyelocytic leukemia. J Clin Oncol.
29:2753–2757. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ren Y, Xie Y, Chai L, Wang S and Cheng M:
Autophagy modification augmented the treatment effects initiated by
arsenic trioxide in NB4 cells. Med Oncol. 28:231–236. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li Y, Qu X, Qu J, Zhang Y, Liu J, Teng Y,
Hu X, Hou K and Liu Y: Arsenic trioxide induces apoptosis and G2/M
phase arrest by inducing Cbl to inhibit PI3K/Akt signaling and
thereby regulate p53 activation. Cancer Lett. 284:208–215. 2009.
View Article : Google Scholar : PubMed/NCBI
|
